LabHealth
NAT10’s helicase domain fuels tumor growth in lab and animal models
Northwestern researchers tested more than 1,900 NAT10 variants in one proliferation assay.
Written by AI1 source1 min
Loading…
Diagnostics, prosthetics, vaccines, genomics: the medicine that adds years to a life.
Northwestern researchers tested more than 1,900 NAT10 variants in one proliferation assay.
L-32 targets PTPN22, a protein that restrains immune activity.
The compound activated PKGIα in animal models and engineered human heart tissue.
Sanford Burnham Prebys researchers identified Firefox and Honeybadger as opposing regulators of MYC-driven tumors.
SHIFTERS uses focused ultrasound to make solid tumor cells briefly display CD19.